Logo

Fulgent Genetics: Brandon Perthuis

Mar 10, 2020

Fulgent Genetics has promoted Brandon Perthuis to chief commercial officer from VP of commercial operations. He will continue to lead the company's global sales organization and commercialization effort and will report to CEO Ming Hsieh. Perthuis came to Fulgent in 2017. He carries 16 years of experience in clinical genetics, including a stint as VP of sales and marketing at Baylor Genetics.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.